Vertex is a biotech company whose primary focus is on drugs for cystic fibrosis (CF), type 1 diabetes, and other rare genetic diseases. The company was founded in 1989 in Boston, Massachusetts. Learn the latest information and analysis on the company, VRTX stock price today, history, stock news, how much one share costs and other information to help you make investment decisions.
Check Gainy app to see how much the price has changed recently as well as insights on stock prices, option prices and more.
Vertex has a monopoly in treatment of cystic fibrosis with its drug Trikafta, which is likely to remain its growth driver for at least a decade. In the last two years the Vertex stock price underperformed the S&P 500 and its peers. Despite this, the company’s fundamentals and financial ratios have improved after encouraging data from a range of drugs nearing approval. According to analysts, VRTX is one of the top biotech stocks with an attractive valuation.
Check back to this page for the VRTX stock quote or download Gainy to always have all the key stock info and stock quotes for all the public stocks right in your pocket.